Tabomedex Biosciences
Latest round
- Series A
Last raised
- Dec 2017
Total raised
- $10M
Investors
- 3
About Tabomedex Biosciences
Based in Massachusetts, US, Tabomedex Biosciences, Inc. is a biotechnology company that focuses on the R&D of new drugs for type 2 diabetes.Ira Tabas is a Professor of medicine and cell biology at Columbia University, and he discovered that hepatocyte signaling has revealed novel drug targets for type 2 diabetes.IRA TABAS also published over 200 papers in journals, such as Cell, Nature, and Science. The company team member, Lale Ozcan, is an Assistant Professor in the Department of Medicine at Columbia University Medical Center and her work focuses on exploring novel signaling pathways that control metabolic homeostasis. The company foucses on the R&D of new drugs related to type 2 diabetes. They study the mechanism of action of MK2 and achieve the effect of controlling blood glucose levels by inhibiting MK2. The company's research reports include that mouse studies point to kinase as a diabetes treatment target, and a new link between obesity and diabetes was found.
Who invested in Tabomedex Biosciences
3 investors across 2 rounds
See all investors in Tabomedex Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tabomedex Biosciences
Who invested in Tabomedex Biosciences?
Tabomedex Biosciences has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tabomedex Biosciences raised?
Tabomedex Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Tabomedex Biosciences last raise money?
Tabomedex Biosciences's most recent round on record is a Series A, in Dec 2017.
What does Tabomedex Biosciences do?
Based in Massachusetts, US, Tabomedex Biosciences, Inc.
Where is Tabomedex Biosciences headquartered?
Tabomedex Biosciences is headquartered in Boston, US.
Which VCs invest in companies like Tabomedex Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tabomedex Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Tabomedex Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.